IRhythm Technologies Net Income Over Time
| IRTC Stock | USD 152.22 3.72 2.51% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out IRhythm Technologies Performance and IRhythm Technologies Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could IRhythm diversify its offerings? Factors like these will boost the valuation of IRhythm Technologies. Market participants price IRhythm higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every IRhythm Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.60) | Revenue Per Share | Quarterly Revenue Growth 0.307 | Return On Assets | Return On Equity |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, IRhythm Technologies' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare iRhythm Technologies and related stocks such as Bruker, Glaukos Corp, and BrightSpring Health Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRKR | (888 K) | 92.3 M | 77.5 M | 80.1 M | 56.7 M | 101.6 M | 153.6 M | 78.6 M | 179.7 M | 197.2 M | 157.8 M | 277.1 M | 296.6 M | 427.2 M | 113.1 M | 130.1 M | 104.3 M |
| GKOS | (19.3 M) | (19.3 M) | (19.3 M) | (12.6 M) | (12.1 M) | (37.2 M) | 4.5 M | (92 K) | (13 M) | 15.4 M | (120.3 M) | (49.6 M) | (99.2 M) | (134.7 M) | (146.4 M) | (131.7 M) | (125.1 M) |
| BTSG | (7.6 M) | (7.6 M) | (7.6 M) | (7.6 M) | (7.6 M) | (7.6 M) | (7.6 M) | (7.6 M) | (7.6 M) | (72.4 M) | 20.8 M | 49.8 M | (53.9 M) | (154.6 M) | (18.1 M) | (16.3 M) | (17.1 M) |
| CHE | 21.9 M | 86 M | 89.3 M | 77.2 M | 99.3 M | 110.3 M | 108.7 M | 98.2 M | 205.5 M | 219.9 M | 319.5 M | 268.6 M | 249.6 M | 272.5 M | 302 M | 347.3 M | 364.7 M |
| CRSP | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (6.8 M) | (25.8 M) | (23.2 M) | (68.4 M) | (165 M) | 66.9 M | (348.9 M) | 377.7 M | (650.2 M) | (153.6 M) | (366.3 M) | (329.6 M) | (313.1 M) |
| PCVX | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (29.5 M) | (50.3 M) | (89.2 M) | (100.1 M) | (223.5 M) | (402.3 M) | (463.9 M) | (417.5 M) | (396.7 M) |
| BLCO | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 298 M | (18 M) | 182 M | 6 M | (260 M) | (317 M) | (285.3 M) | (271 M) |
| ARWR | (854.5 K) | (21.1 M) | (31.1 M) | (58.6 M) | (91.9 M) | (81.7 M) | (34.4 M) | (54.5 M) | 68 M | (84.6 M) | (140.8 M) | (176.5 M) | (205.3 M) | (599.5 M) | (1.6 M) | (1.5 M) | (1.5 M) |
| TFX | 13.3 M | 323.3 M | (190.1 M) | 150.9 M | 187.7 M | 244.9 M | 237.4 M | 152.5 M | 200.8 M | 461.5 M | 335.3 M | 485.4 M | 363.1 M | 356.3 M | 69.7 M | 80.1 M | 151.6 M |
iRhythm Technologies and related stocks such as Bruker, Glaukos Corp, and BrightSpring Health Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in iRhythm Technologies financial statement analysis. It represents the amount of money remaining after all of iRhythm Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| iRhythm Technologies | IRTC |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 699 8th Street, |
| Exchange | NASDAQ Exchange |
USD 152.22
Check out IRhythm Technologies Performance and IRhythm Technologies Correlation. For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
IRhythm Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.